EU Project Takes ACTION with Bio, Grid and Nano Technology Development

European researchers have forged a partnership with counterparts in the Western Balkans, North Africa and Latin America to strengthen cooperation in the fields of biomedical informatics (BMI), grid technologies and nanoinformatics. Their work is being carried out through ACTION-Grid, a project supported by the EU's Seventh Framework Programme (FP7) with funding totalling some €1 million. ACTION-Grid kicked off in June and will run for a period of 18 months.

The ACTION-Grid consortium aims to maximise the potential of biomedical data and computing resources. The project partners' work effectively reinforces the European Commission's position that research groups improve their understanding of activities carried out in target countries such as those from the Western Balkans and Latin America. The partners will focus on finding and fuelling cooperation, as well as identifying viable activities for the future. Besides establishing a collaborative environment between the regions, the seven-member consortium will exchange research results and contribute to improving the EU's Research Programme in a specific area.

Their work will develop training and mobility in BMI, grid and nanoinformatics. The consortium says the results will be integrated with data from an automated 'resourceome', an inventory of BMI/grid/nano methods and services developed by the ACTION-Grid team. This inventory can be accessed by researchers and users. Ultimately, the resourceome will enable researchers - from the across the board - to access the new technologies developed in the EU.

With support from a panel of recognised experts, the consortium will also develop a White Paper, which will be presented to the EC so as to initiate new plans in the regions in question.

The dissemination of the ACTION-Grid results will be made possible via an international symposium on BMI and grid, as well as scientific publications, newsletters, press releases and a website.

The upshot of the ACTION-Grid project is that major achievements in the fields of BMI and grid computing, including tools, expertise and methods, can be reused and transferred to the Western Balkans, North Africa and Latin America. The knowledge gained in ACTION-Grid will also be incurred from key successes achieved by the consortium in the past. Examples include past EU-backed GRID-based projects, including Gripps, MediGrid, GLOP and eDiamond.

The EU has been relentless in its pursuit over the last 10 years to establish and implement initiatives linking clinical data and results from a myriad of projects, methods and tools in the BMI area. It should be noted that EU research in the areas of genomic and personalised medicine has encouraged scientists to participate in the various research projects that have got off the ground in the region.

Specifically, the link between ACTION-Grid and the field of medicine is nanoinformatics; ACTION-Grid is the EU's maiden project targeting the development of this discipline. The consortium says nanomedicine has the capacity to meliorate existing diagnostic methods and treatments.

Coordinated by the Biomedical Informatics Group at the Madrid Polytechnic University in Spain, ACTION-Grid brings together partners from Argentina, Chile, Croatia, France and Greece.

For further information, please visit:
http://www.action-grid.eu/

Related article:

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...